Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Harris Associates Concentrated Strategy's investment thesis on Unicharm Corporation ($8113.T) — Q1 2026 | Buyside Digest

$8113.TNASDAQUnicharm Corporation

BULL

Harris Associates Concentrated Strategy—8113.T

Fund Letter

Q1 2026

Published March 31, 2026

$987.70USD

+1.9% vs last month

$960.80Pitched

+2.8% since pitch

Market Cap$1.72T

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Unicharm is a leading global personal care company, best known for products across feminine hygiene, adult incontinence, and baby diapers.

— Tony Coniaris

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on Unicharm Corporation

No other institutional pitches found for this ticker yet.